Management of the axilla

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Sentinel lymph node biopsy (SLNB) has revolutionized breast cancer staging.
• Axillary lymph node dissection (ALND) traditionally involved significant patient morbidity.
• Accurate staging is crucial for guiding adjuvant treatment decisions.

Purpose of the Study:

• To evaluate the impact of SLNB on breast cancer management.
• To assess the diagnostic accuracy and prognostic value of SLNB compared to ALND.
• To discuss the evolving role of ALND in minimally invasive breast cancer treatment.

Main Methods:

• Review of clinical data and management guidelines for early-stage breast cancer.
• Comparative analysis of outcomes between SLNB and ALND in node-negative patients.
• Assessment of SLNB's role in treatment decision-making.

Main Results:

• SLNB effectively spares patients the morbidity associated with ALND.
• SLNB provides comparable diagnostic accuracy and prognostic information to ALND.
• SLNB has become a standard tool for guiding adjuvant therapy in early-stage breast cancer.

Conclusions:

• SLNB is a highly effective and less invasive alternative to ALND for node-negative breast cancer.
• The utility of ALND is diminishing with advancements in minimally invasive surgical techniques.
• Continued evolution towards less invasive breast cancer management strategies is expected.